GenIP plc (AIM: GNIP), an AI-driven services provider helping research organisations and corporations commercialise innovations, has issued a commercial update on the soft launch of its Invention Evaluator Platform. The company identified 17 pilot accounts across several international markets, with management estimating these accounts alone could represent a potential annual subscription value of around US$170,000 in aggregate. The full commercial launch remains on track for December 2026, and the board says the business will continue to trade in line with management expectations for the remainder of 2026.

Key Points

  • GenIP plc (AIM: GNIP) — AI-driven innovation commercialisation services provider
  • Soft launch of Invention Evaluator Platform completed with positive customer feedback; full commercial launch targeted for December 2026
  • 17 pilot accounts identified; potential sales pipeline estimated at approximately US$1.0 million; total addressable market estimated at approximately US$50 million per annum
  • Investors should watch for conversion of pipeline into confirmed orders and first paid platform subscriptions

GenIP's Invention Evaluator Platform Receives Positive Trial Feedback From 17 Pilot Accounts

Several customers successfully trialled the Invention Evaluator Platform following its soft launch, which was originally announced on 19 October 2026. The announcement states that initial feedback has been positive, with customers preferring the platform's new features and its streamlined, action-oriented approach to managing and prioritising technologies. Among the 17 pilot accounts identified across several international markets, one significant customer from 2025 has already agreed to initiate a migration plan as an early adopter. Management estimates these pilot accounts alone could represent a potential annual subscription value of around US$170,000 in aggregate, though the company notes this is not contracted ARR or a revenue forecast.

December 2026 Commercial Launch Targets GenIP's Historical Base of Approximately 300 Customers

The full commercial launch of the subscription-based Invention Evaluator Platform remains on track for December 2026. Following the launch, GenIP intends to target its historical customer base of approximately 300 customers, presenting them with a migration path to the new subscription model. Management has also revised its estimate of the global total addressable market upward to approximately US$50 million per annum, before additional services, based on early feedback and ongoing customer conversations. The company's revenue model is transitioning towards recurring subscriptions, which the board believes will strengthen its financial foundation with significant levels of recurring revenue.

New Customers Secured in Chile and Brazil as GenIP Expands Across Latin America and Asia

GenIP continues to secure orders for its existing services, including from universities in Chile and Brazil, a Brazilian technology company, and a Spanish university-industry collaboration network. Following the appointment of a sales representative in Chile, the company secured three new customers and reactivated two historical customer relationships across South America. The announcement also highlights growing engagement from commercial and corporate customers, including opportunities with organisations associated with Saudi Aramco and advanced proposal discussions with Amazon Web Services in Brazil. In aggregate, management estimates these potential customers represent a sales pipeline of approximately US$1.0 million, though again this figure is not contracted revenue.

Board Targets 40% Reduction in Cash Burn During 2027 as Platform Transition Progresses

GenIP's board states it remains confident the business will trade in line with management expectations for the remainder of 2026 and targets a reduction in cash burn of approximately 40% in 2027 as the business transitions to a stronger foundation with higher recurring revenues. The company's immediate priorities, as stated in the announcement, are to convert its growing sales pipeline into confirmed orders, secure its first paid platform subscriptions, and demonstrate improved delivery margins. Investors may be watching closely for evidence of subscription conversion rates as GenIP moves from its soft launch phase into a full commercial rollout in December 2026.